112 related articles for article (PubMed ID: 16328028)
21. Impressive regression of visceral and cerebral melanoma metastases under combination treatment including dacarbacine, radiotherapy and celecoxib.
Becker MR; Gaiser T
Int J Dermatol; 2009 Feb; 48(2):207-9. PubMed ID: 19200209
[No Abstract] [Full Text] [Related]
22. CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide.
Kast RE; Karpel-Massler G; Halatsch ME
Oncotarget; 2014 Sep; 5(18):8052-82. PubMed ID: 25211298
[TBL] [Abstract][Full Text] [Related]
23. Celecoxib prevents neuroblastoma tumor development and potentiates the effect of chemotherapeutic drugs in vitro and in vivo.
Ponthan F; Wickström M; Gleissman H; Fuskevåg OM; Segerström L; Sveinbjörnsson B; Redfern CP; Eksborg S; Kogner P; Johnsen JI
Clin Cancer Res; 2007 Feb; 13(3):1036-44. PubMed ID: 17289900
[TBL] [Abstract][Full Text] [Related]
24. Intracranial inhibition of glioma cell growth by cyclooxygenase-2 inhibitor celecoxib.
Nam DH; Park K; Park C; Im YH; Kim MH; Lee S; Hong SC; Shin HJ; Kim JH; Eoh W; McDonnell TJ
Oncol Rep; 2004 Feb; 11(2):263-8. PubMed ID: 14719052
[TBL] [Abstract][Full Text] [Related]
25. Celecoxib desensitization: continued temozolomide/celecoxib chemotherapy after a celecoxib-induced hypersensitivity reaction.
Burbach GJ; Vajkoczy P; Zuberbier T
Anticancer Drugs; 2012 Nov; 23(10):1118-20. PubMed ID: 23026982
[TBL] [Abstract][Full Text] [Related]
26. Temozolomide reverses doxorubicin resistance by inhibiting P-glycoprotein in malignant glioma cells.
Zhang R; Saito R; Shibahara I; Sugiyama S; Kanamori M; Sonoda Y; Tominaga T
J Neurooncol; 2016 Jan; 126(2):235-42. PubMed ID: 26530267
[TBL] [Abstract][Full Text] [Related]
27. Phase I study of temozolomide and escalating doses of oral etoposide for adults with recurrent malignant glioma.
Korones DN; Benita-Weiss M; Coyle TE; Mechtler L; Bushunow P; Evans B; Reardon DA; Quinn JA; Friedman H
Cancer; 2003 Apr; 97(8):1963-8. PubMed ID: 12673724
[TBL] [Abstract][Full Text] [Related]
28. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV
Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579
[TBL] [Abstract][Full Text] [Related]
29. Celecoxib modulates the expression of cyclooxygenase-2, ki67, apoptosis-related marker, and microvessel density in human cervical cancer: a pilot study.
Ferrandina G; Ranelletti FO; Legge F; Lauriola L; Salutari V; Gessi M; Testa AC; Werner U; Navarra P; Tringali G; Battaglia A; Scambia G
Clin Cancer Res; 2003 Oct; 9(12):4324-31. PubMed ID: 14555502
[TBL] [Abstract][Full Text] [Related]
30. Phase-1 trial of gefitinib and temozolomide in patients with malignant glioma: a North American brain tumor consortium study.
Prados MD; Yung WK; Wen PY; Junck L; Cloughesy T; Fink K; Chang S; Robins HI; Dancey J; Kuhn J
Cancer Chemother Pharmacol; 2008 May; 61(6):1059-67. PubMed ID: 17694310
[TBL] [Abstract][Full Text] [Related]
31. Temozolomide delivered by intracerebral microinfusion is safe and efficacious against malignant gliomas in rats.
Heimberger AB; Archer GE; McLendon RE; Hulette C; Friedman AH; Friedman HS; Bigner DD; Sampson JH
Clin Cancer Res; 2000 Oct; 6(10):4148-53. PubMed ID: 11051269
[TBL] [Abstract][Full Text] [Related]
32. Low-dose chemotherapy in combination with COX-2 inhibitors and PPAR-gamma agonists in recurrent high-grade gliomas - a phase II study.
Hau P; Kunz-Schughart L; Bogdahn U; Baumgart U; Hirschmann B; Weimann E; Muhleisen H; Ruemmele P; Steinbrecher A; Reichle A
Oncology; 2007; 73(1-2):21-5. PubMed ID: 18332649
[TBL] [Abstract][Full Text] [Related]
33. Temozolomide and treatment of malignant glioma.
Friedman HS; Kerby T; Calvert H
Clin Cancer Res; 2000 Jul; 6(7):2585-97. PubMed ID: 10914698
[TBL] [Abstract][Full Text] [Related]
34. Finding drugs against CD133+ glioma subpopulations.
Nakano I; Chiocca EA
J Neurosurg; 2011 Mar; 114(3):648; discussion 648-50. PubMed ID: 21054138
[No Abstract] [Full Text] [Related]
35. [Chemopreventive effect of tamoxifen combined with celecoxib on DMBA-induced breast cancer in rats].
Kang HF; Wang XJ; Liu XX; Dai ZJ; Xue FJ; Xue XH
Ai Zheng; 2006 Nov; 25(11):1346-50. PubMed ID: 17094899
[TBL] [Abstract][Full Text] [Related]
36. [Inhibitive effect of celecoxib combined with tegafur gimeracil oteracil potassium on the growth of xenograft tumor of gastric cancer in nude mice].
Meng C; Chen X; Luo Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 May; 29(5):458-61. PubMed ID: 23643260
[TBL] [Abstract][Full Text] [Related]
37. Exisulind in combination with celecoxib modulates epidermal growth factor receptor, cyclooxygenase-2, and cyclin D1 against prostate carcinogenesis: in vivo evidence.
Narayanan BA; Reddy BS; Bosland MC; Nargi D; Horton L; Randolph C; Narayanan NK
Clin Cancer Res; 2007 Oct; 13(19):5965-73. PubMed ID: 17908994
[TBL] [Abstract][Full Text] [Related]
38. Preclinical antitumor activity of temozolomide in mice: efficacy against human brain tumor xenografts and synergism with 1,3-bis(2-chloroethyl)-1-nitrosourea.
Plowman J; Waud WR; Koutsoukos AD; Rubinstein LV; Moore TD; Grever MR
Cancer Res; 1994 Jul; 54(14):3793-9. PubMed ID: 8033099
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of 5-lipoxygenase in rat and human esophageal adenocarcinoma and inhibitory effects of zileuton and celecoxib on carcinogenesis.
Chen X; Wang S; Wu N; Sood S; Wang P; Jin Z; Beer DG; Giordano TJ; Lin Y; Shih WC; Lubet RA; Yang CS
Clin Cancer Res; 2004 Oct; 10(19):6703-9. PubMed ID: 15475461
[TBL] [Abstract][Full Text] [Related]
40. Antitumor properties of dimethyl-celecoxib, a derivative of celecoxib that does not inhibit cyclooxygenase-2: implications for glioma therapy.
Schönthal AH
Neurosurg Focus; 2006 Apr; 20(4):E21. PubMed ID: 16709027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]